SWATH-proteomics reveals Mathurameha, a traditional anti-diabetic herbal formula, attenuates high glucose-induced endothelial dysfunction through the EGF/NO/IL-1β regulatory axis
dc.contributor.author | Aluksanasuwan S. | |
dc.contributor.author | Somsuan K. | |
dc.contributor.author | Chiangjong W. | |
dc.contributor.author | Rongjumnong A. | |
dc.contributor.author | Jaidee W. | |
dc.contributor.author | Rujanapun N. | |
dc.contributor.author | Chutipongtanate S. | |
dc.contributor.author | Laphookhieo S. | |
dc.contributor.author | Charoensup R. | |
dc.contributor.correspondence | Aluksanasuwan S. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-07-30T18:29:19Z | |
dc.date.available | 2024-07-30T18:29:19Z | |
dc.date.issued | 2024-08-30 | |
dc.description.abstract | Mathurameha is a traditional Thai herbal formula with a clinically proven effect of blood sugar reduction in patients with diabetes mellitus, but its anti-diabetic complication potential is largely unknown. This study aimed to elucidate the effects of Mathurameha and its underlying mechanisms against high glucose-induced endothelial dysfunction in human endothelial EA.hy926 cells. After confirming no cytotoxic effects, the cells were treated with normal glucose (NG), high glucose (HG), or high glucose plus Mathurameha (HG + M) for 24 h. A quantitative label-free proteomic analysis using the sequential window acquisition of all theoretical mass spectra (SWATH-MS) approach identified 24 differentially altered proteins among the three groups: 7 between HG and NG, 9 between HG + M and NG, and 13 between HG + M and HG. Bioinformatic analyses suggested a potential anti-diabetic action through the epidermal growth factor (EGF) pathway. Subsequent functional validations demonstrated that Mathurameha reduced the EGF secretion and the intracellular reactive oxygen species (ROS) level in high glucose-treated cells. Mathurameha also exhibited a stimulatory effect on nitric oxide (NO) production while significantly reducing the secretion of endothelin-1 (ET-1) and interleukin-1β (IL-1β) in high glucose-treated cells. In conclusion, our findings demonstrated that Mathurameha attenuated high glucose-induced endothelial dysfunction through the EGF/NO/IL-1β regulatory axis. Significance: This study reveals the potential of Mathurameha, a traditional Thai herbal formula, in mitigating high glucose-induced endothelial dysfunction, a common complication in diabetes mellitus. Using proteomics and bioinformatic analyses followed by functional validations, the present study highlights the protective effects of Mathurameha through the EGF/NO/IL-1β regulatory axis. These findings support its potential use as a therapeutic intervention for diabetic vascular complications and provide valuable information for developing more effective anti-diabetic drugs. | |
dc.identifier.citation | Journal of Proteomics Vol.306 (2024) | |
dc.identifier.doi | 10.1016/j.jprot.2024.105263 | |
dc.identifier.eissn | 18767737 | |
dc.identifier.issn | 18743919 | |
dc.identifier.scopus | 2-s2.0-85199352006 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/100061 | |
dc.rights.holder | SCOPUS | |
dc.subject | Biochemistry, Genetics and Molecular Biology | |
dc.title | SWATH-proteomics reveals Mathurameha, a traditional anti-diabetic herbal formula, attenuates high glucose-induced endothelial dysfunction through the EGF/NO/IL-1β regulatory axis | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85199352006&origin=inward | |
oaire.citation.title | Journal of Proteomics | |
oaire.citation.volume | 306 | |
oairecerif.author.affiliation | School of Medicine, Mae Fah Luang University | |
oairecerif.author.affiliation | Mae Fah Luang University | |
oairecerif.author.affiliation | University of Cincinnati College of Medicine | |
oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University |